Aug
05
2009

Cystic fibrosis drug wins 'orphan' status

European drug regulators have given Aradigm Corp. ‘s inhaled cystic fibrosis drug “orphan” status.

Written by fibrosis news in: Cystic Fibrosis | Tags: ,

No Comments »

RSS feed for comments on this post. TrackBack URL


Leave a Reply

You must be logged in to post a comment.

Bookmark Us!

©Uncle & Drunken Crayfish Productions 2011 www.DrunkenCrayfish.com DrunkenCrayfish

Visit our NEW site at PocketBiker.com
PocketBiker.com Logo

 

TheBuckmaker.com Wordpress Themes | Hosting Provider, Mixed-Tape Free Music